| 2024 Rome, Italy E Ollier, X Delavenne, T Basset, A Samson | | |
| A diagnostic solution for lupus anticoagulant testing in patients taking direct oral FXa inhibitors using DOAC filter C Farkh, S Ellouze, L Gounelle, M Sad Houari, J Duchemin, V Proulle, ... Frontiers in Medicine 8, 683357, 2021 | 20 | 2021 |
| A French real-world evidence study evaluating the efficacy, safety, and pharmacokinetic parameters of rVIII-SingleChain in patients with hemophilia A receiving prophylaxis B Guillet, A Hassoun, B Wibaut, A Harroche, C Biron-Andréani, ... Thrombosis and Haemostasis 123 (05), 490-500, 2023 | 1 | 2023 |
| A new paradigm for personalized prophylaxis for patients with severe haemophilia A X Delavenne, E Ollier, A Lienhart, Y Dargaud Haemophilia 26 (2), 228-235, 2020 | 24 | 2020 |
| A new strategy to improve drug delivery to the maxillary sinuses: the frequency sweep acoustic airflow A El Merhie, L Navarro, X Delavenne, L Leclerc, J Pourchez Pharmaceutical research 33, 1074-1084, 2016 | 15 | 2016 |
| A Pharmacokinetic-Pharmacodynamic Model for Predicting the Impact of CYP2C9 and VKORC1 Polymorphisms on Fluindione and Acenocoumarol During … C Verstuyft, X Delavenne, A Rousseau, A Robert, M Tod, B Diquet, ... Clinical pharmacokinetics 51, 41-53, 2012 | 30 | 2012 |
| A SAEM algorithm for fused lasso penalized nonlinear mixed effect models: application to group comparison in pharmacokinetics E Ollier, A Samson, X Delavenne, V Viallon Computational Statistics & Data Analysis 95, 207-221, 2016 | 9 | 2016 |
| A semi‐mechanistic absorption model to evaluate drug–drug interaction with dabigatran: application with clarithromycin X Delavenne, E Ollier, T Basset, L Bertoletti, S Accassat, A Garcin, ... British journal of clinical pharmacology 76 (1), 107-113, 2013 | 94 | 2013 |
| AB0277 ASSOCIATION BETWEEN INTRA-ERYTHROCYTE METHOTREXATE POLYGLUTAMATE CONCENTRATION AND CLINICAL RESPONSE IN RHEUMATOID ARTHRITIS IN PATIENTS TREATED WITH METHOTREXATE … M Poudret, M Norman, S Hodin, AS Amouzougan, K Boussoualim, ... Annals of the Rheumatic Diseases 80 (Suppl 1), 1164-1164, 2021 | 1 | 2021 |
| Absence d’association entre la concentration du polyglutamate intra-érythrocytaire du méthotrexate et la réponse clinique au cours de la polyarthrite rhumatoïde (étude POLYGLU) M Poudret, M Normand, S Audin, SA Amouzougan, K Boussoualim, ... Revue du Rhumatisme 88, A126-A127, 2021 | | 2021 |
| Accidental apixaban intoxication in a 23-month-old child: a case report M Launay, Y Nasser, I Maubert, AC Chaux, X Delavenne BMC pediatrics 20, 1-4, 2020 | 5 | 2020 |
| Acoustic aerosol delivery: assessing of various nasal delivery techniques and medical devices on intrasinus drug deposition L Leclerc, N Prévôt, S Hodin, X Delavenne, H Mentzel, U Schuschnig, ... Pharmaceuticals 16 (2), 135, 2023 | 3 | 2023 |
| Améliorations pharmacologiques apportées par les nouveaux anticoagulants oraux X Delavenne La presse médicale 42 (9), 1206-1212, 2013 | 10 | 2013 |
| An indirect PK-PD model to assess interaction between acenocoumarol and amoxicillin plus clavulanic acid X Delavenne, T Basset, N Moulin, JP Gay, H Decousus, P Mismetti, ... FUNDAMENTAL & CLINICAL PHARMACOLOGY 21, 8-8, 2007 | | 2007 |
| Antidotes et anticoagulants oraux directs: développement et stratégies d’utilisation actuelles et futures P Mismetti, E Ollier, F Bellet, X Delavenne | | |
| Antipsychotics: a real or confounding risk factor for venous thromboembolism? C Chapelle, S Quenet, X Delavenne, K Lacut, P Mismetti, S Laporte, ... Pharmacopsychiatry 46 (01), 36-37, 2013 | 11 | 2013 |
| Antithrombotics in pulmonary hypertension: more work needed before we turn to newer agents! L Bertoletti, X Delavenne, D Montani European Respiratory Journal 41 (4), 775-777, 2013 | 13 | 2013 |
| Apixaban: determination of its anticoagulant effects and influence on coagulation tests: a multicentre French GEHT study I Gouin-Thibault, C Flaujac, S Quenet, MH Horellou, X Delavenne, ... JOURNAL OF THROMBOSIS AND HAEMOSTASIS 11, 256-256, 2013 | | 2013 |
| Apports des modèles non linéaires à effets mixtes dans l'étude de la variabilité pharmacocinétique et pharmacodynamique des médicaments antithrombotiques X Delavenne Université Jean Monnet-Saint-Etienne, 2011 | 1 | 2011 |
| Assessment of apixaban plasma levels by laboratory tests: suitability of three anti-Xa assays I Gouin-Thibault, C Flaujac, X Delavenne, S Quenet, MH Horellou, ... Thrombosis and haemostasis 112 (02), 240-248, 2014 | 149 | 2014 |
silvy laportesaint-etienne在 chu-st-etienne.fr 的电子邮件经过验证
